HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The antiarrhythmic efficacy of intravenous therapy with disopyramide phosphate.

Abstract
Disopyramide phosphate was administered intravenously to 57 patients with 60 episodes of arrhythmia (21 supraventricular and 39 ventricular) as a 2 mg/kg bolus. Conversion to sinus rhythm was achieved in three (38 percent) of eight patients with atrial flutter, two (20 percent) of ten patients with atrial fibrillation, one (33 percent) of three patients with paroxysmal atrial tachycardia, and two (50 percent) of four patients with sustained ventricular tachycardia. In nine (75 percent) of 12 patients with nonsustained ventricular tachycardia, suppression of the arrhythmia was accomplished following the intravenous bolus of disopyramide. In 18 (78 percent) of 23 patients with frequent ventricular premature contractions, greater than 50 percent suppression of the ventricular premature contractions was achieved. These effects were satisfactorily maintained in six (86 percent) of seven patients with nonsustained ventricular tachycardia and in 14 (88 percent) of 16 patients with frequent ventricular premature contractions in whom therapy with disopyramide phosphate was continued as a 20 mg/hour intravenous drip infusion for up to 24 hours. Side effects were observed in only eight patients (14 percent) and were primarily anticholinergic in nature. Transient hypotension, not necessitating treatment with pressor agents, was observed in three patients (5 percent), in two of whom discontinuance of therapy with disopyramide was deemed necessary. Intravenous therapy with disopyramide in the dosage regimen employed appears to be moderately effective against supraventricular arrhythmia and particularly effective against ventricular arrhythmia with minimal toxicity. It appears to be a suitable alternative to intravenous therapy with lidocaine and has the additional advantage of availability for oral administration.
AuthorsD A Deano, D Wu, R K Mautner, R H Sherman, A I Ehsani, K M Rosen
JournalChest (Chest) Vol. 71 Issue 5 Pg. 597-606 (May 1977) ISSN: 0012-3692 [Print] United States
PMID856558 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Pyridines
  • Disopyramide
Topics
  • Administration, Oral
  • Adult
  • Aged
  • Arrhythmias, Cardiac (drug therapy)
  • Atrial Fibrillation (drug therapy)
  • Atrial Flutter (drug therapy)
  • Disopyramide (administration & dosage, adverse effects, therapeutic use)
  • Drug Evaluation
  • Female
  • Humans
  • Injections, Intravenous
  • Male
  • Middle Aged
  • Pyridines (therapeutic use)
  • Tachycardia (drug therapy)
  • Tachycardia, Paroxysmal (drug therapy)
  • Wolff-Parkinson-White Syndrome (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: